Chapter/Section Purchase

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Line and Sample Identification Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Cell Line Identity
1.2.3 Genetic Stability
1.2.4 Virus Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cell Line and Sample Identification Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical and Biopharmaceutical Company
1.3.3 Research Laboratory
1.3.4 Hospital
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Line and Sample Identification Market Perspective (2017-2028)
2.2 Cell Line and Sample Identification Growth Trends by Region
2.2.1 Cell Line and Sample Identification Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell Line and Sample Identification Historic Market Size by Region (2017-2022)
2.2.3 Cell Line and Sample Identification Forecasted Market Size by Region (2023-2028)
2.3 Cell Line and Sample Identification Market Dynamics
2.3.1 Cell Line and Sample Identification Industry Trends
2.3.2 Cell Line and Sample Identification Market Drivers
2.3.3 Cell Line and Sample Identification Market Challenges
2.3.4 Cell Line and Sample Identification Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Line and Sample Identification Players by Revenue
3.1.1 Global Top Cell Line and Sample Identification Players by Revenue (2017-2022)
3.1.2 Global Cell Line and Sample Identification Revenue Market Share by Players (2017-2022)
3.2 Global Cell Line and Sample Identification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Line and Sample Identification Revenue
3.4 Global Cell Line and Sample Identification Market Concentration Ratio
3.4.1 Global Cell Line and Sample Identification Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Line and Sample Identification Revenue in 2021
3.5 Cell Line and Sample Identification Key Players Head office and Area Served
3.6 Key Players Cell Line and Sample Identification Product Solution and Service
3.7 Date of Enter into Cell Line and Sample Identification Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Line and Sample Identification Breakdown Data by Type
4.1 Global Cell Line and Sample Identification Historic Market Size by Type (2017-2022)
4.2 Global Cell Line and Sample Identification Forecasted Market Size by Type (2023-2028)
5 Cell Line and Sample Identification Breakdown Data by Application
5.1 Global Cell Line and Sample Identification Historic Market Size by Application (2017-2022)
5.2 Global Cell Line and Sample Identification Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell Line and Sample Identification Market Size (2017-2028)
6.2 North America Cell Line and Sample Identification Market Size by Country (2017-2022)
6.3 North America Cell Line and Sample Identification Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell Line and Sample Identification Market Size (2017-2028)
7.2 Europe Cell Line and Sample Identification Market Size by Country (2017-2022)
7.3 Europe Cell Line and Sample Identification Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Line and Sample Identification Market Size (2017-2028)
8.2 Asia-Pacific Cell Line and Sample Identification Market Size by Country (2017-2022)
8.3 Asia-Pacific Cell Line and Sample Identification Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell Line and Sample Identification Market Size (2017-2028)
9.2 Latin America Cell Line and Sample Identification Market Size by Country (2017-2022)
9.3 Latin America Cell Line and Sample Identification Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Line and Sample Identification Market Size (2017-2028)
10.2 Middle East & Africa Cell Line and Sample Identification Market Size by Country (2017-2022)
10.3 Middle East & Africa Cell Line and Sample Identification Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Promega Corporation
11.1.1 Promega Corporation Company Detail
11.1.2 Promega Corporation Business Overview
11.1.3 Promega Corporation Cell Line and Sample Identification Introduction
11.1.4 Promega Corporation Revenue in Cell Line and Sample Identification Business (2017-2022)
11.1.5 Promega Corporation Recent Development
11.2 Secugen
11.2.1 Secugen Company Detail
11.2.2 Secugen Business Overview
11.2.3 Secugen Cell Line and Sample Identification Introduction
11.2.4 Secugen Revenue in Cell Line and Sample Identification Business (2017-2022)
11.2.5 Secugen Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Cell Line and Sample Identification Introduction
11.3.4 Thermo Fisher Scientific Revenue in Cell Line and Sample Identification Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Sphere Fluidics
11.4.1 Sphere Fluidics Company Detail
11.4.2 Sphere Fluidics Business Overview
11.4.3 Sphere Fluidics Cell Line and Sample Identification Introduction
11.4.4 Sphere Fluidics Revenue in Cell Line and Sample Identification Business (2017-2022)
11.4.5 Sphere Fluidics Recent Development
11.5 Creative Bioarray
11.5.1 Creative Bioarray Company Detail
11.5.2 Creative Bioarray Business Overview
11.5.3 Creative Bioarray Cell Line and Sample Identification Introduction
11.5.4 Creative Bioarray Revenue in Cell Line and Sample Identification Business (2017-2022)
11.5.5 Creative Bioarray Recent Development
11.6 MD Anderson
11.6.1 MD Anderson Company Detail
11.6.2 MD Anderson Business Overview
11.6.3 MD Anderson Cell Line and Sample Identification Introduction
11.6.4 MD Anderson Revenue in Cell Line and Sample Identification Business (2017-2022)
11.6.5 MD Anderson Recent Development
11.7 Bio-Synthesis, Inc.
11.7.1 Bio-Synthesis, Inc. Company Detail
11.7.2 Bio-Synthesis, Inc. Business Overview
11.7.3 Bio-Synthesis, Inc. Cell Line and Sample Identification Introduction
11.7.4 Bio-Synthesis, Inc. Revenue in Cell Line and Sample Identification Business (2017-2022)
11.7.5 Bio-Synthesis, Inc. Recent Development
11.8 Cell Line Genetics, Inc.
11.8.1 Cell Line Genetics, Inc. Company Detail
11.8.2 Cell Line Genetics, Inc. Business Overview
11.8.3 Cell Line Genetics, Inc. Cell Line and Sample Identification Introduction
11.8.4 Cell Line Genetics, Inc. Revenue in Cell Line and Sample Identification Business (2017-2022)
11.8.5 Cell Line Genetics, Inc. Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Detail
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories Cell Line and Sample Identification Introduction
11.9.4 Charles River Laboratories Revenue in Cell Line and Sample Identification Business (2017-2022)
11.9.5 Charles River Laboratories Recent Development
11.10 DNA Forensics Lab India
11.10.1 DNA Forensics Lab India Company Detail
11.10.2 DNA Forensics Lab India Business Overview
11.10.3 DNA Forensics Lab India Cell Line and Sample Identification Introduction
11.10.4 DNA Forensics Lab India Revenue in Cell Line and Sample Identification Business (2017-2022)
11.10.5 DNA Forensics Lab India Recent Development
11.11 Eurofins Genomics (Eurofins Scientific)
11.11.1 Eurofins Genomics (Eurofins Scientific) Company Detail
11.11.2 Eurofins Genomics (Eurofins Scientific) Business Overview
11.11.3 Eurofins Genomics (Eurofins Scientific) Cell Line and Sample Identification Introduction
11.11.4 Eurofins Genomics (Eurofins Scientific) Revenue in Cell Line and Sample Identification Business (2017-2022)
11.11.5 Eurofins Genomics (Eurofins Scientific) Recent Development
11.12 GenomeScan
11.12.1 GenomeScan Company Detail
11.12.2 GenomeScan Business Overview
11.12.3 GenomeScan Cell Line and Sample Identification Introduction
11.12.4 GenomeScan Revenue in Cell Line and Sample Identification Business (2017-2022)
11.12.5 GenomeScan Recent Development
11.13 IDEXX Laboratories, Inc.
11.13.1 IDEXX Laboratories, Inc. Company Detail
11.13.2 IDEXX Laboratories, Inc. Business Overview
11.13.3 IDEXX Laboratories, Inc. Cell Line and Sample Identification Introduction
11.13.4 IDEXX Laboratories, Inc. Revenue in Cell Line and Sample Identification Business (2017-2022)
11.13.5 IDEXX Laboratories, Inc. Recent Development
11.14 Laboratory Corporation of America Holdings
11.14.1 Laboratory Corporation of America Holdings Company Detail
11.14.2 Laboratory Corporation of America Holdings Business Overview
11.14.3 Laboratory Corporation of America Holdings Cell Line and Sample Identification Introduction
11.14.4 Laboratory Corporation of America Holdings Revenue in Cell Line and Sample Identification Business (2017-2022)
11.14.5 Laboratory Corporation of America Holdings Recent Development
11.15 Microsynth AG
11.15.1 Microsynth AG Company Detail
11.15.2 Microsynth AG Business Overview
11.15.3 Microsynth AG Cell Line and Sample Identification Introduction
11.15.4 Microsynth AG Revenue in Cell Line and Sample Identification Business (2017-2022)
11.15.5 Microsynth AG Recent Development
11.16 NorthGene Limited (Biofortuna Limited)
11.16.1 NorthGene Limited (Biofortuna Limited) Company Detail
11.16.2 NorthGene Limited (Biofortuna Limited) Business Overview
11.16.3 NorthGene Limited (Biofortuna Limited) Cell Line and Sample Identification Introduction
11.16.4 NorthGene Limited (Biofortuna Limited) Revenue in Cell Line and Sample Identification Business (2017-2022)
11.16.5 NorthGene Limited (Biofortuna Limited) Recent Development
11.17 Perfectus Biomed Limited
11.17.1 Perfectus Biomed Limited Company Detail
11.17.2 Perfectus Biomed Limited Business Overview
11.17.3 Perfectus Biomed Limited Cell Line and Sample Identification Introduction
11.17.4 Perfectus Biomed Limited Revenue in Cell Line and Sample Identification Business (2017-2022)
11.17.5 Perfectus Biomed Limited Recent Development
11.18 SGS SA
11.18.1 SGS SA Company Detail
11.18.2 SGS SA Business Overview
11.18.3 SGS SA Cell Line and Sample Identification Introduction
11.18.4 SGS SA Revenue in Cell Line and Sample Identification Business (2017-2022)
11.18.5 SGS SA Recent Development
11.19 Sigma-Aldrich Co. LLC. (Merck KGaA)
11.19.1 Sigma-Aldrich Co. LLC. (Merck KGaA) Company Detail
11.19.2 Sigma-Aldrich Co. LLC. (Merck KGaA) Business Overview
11.19.3 Sigma-Aldrich Co. LLC. (Merck KGaA) Cell Line and Sample Identification Introduction
11.19.4 Sigma-Aldrich Co. LLC. (Merck KGaA) Revenue in Cell Line and Sample Identification Business (2017-2022)
11.19.5 Sigma-Aldrich Co. LLC. (Merck KGaA) Recent Development
11.20 Frequently Asked Questions
11.20.1 Frequently Asked Questions Company Detail
11.20.2 Frequently Asked Questions Business Overview
11.20.3 Frequently Asked Questions Cell Line and Sample Identification Introduction
11.20.4 Frequently Asked Questions Revenue in Cell Line and Sample Identification Business (2017-2022)
11.20.5 Frequently Asked Questions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details